Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES
OBSERVATIONAL
Inicio: 6 de ago de 2020
ID: NCT04482361
Completado
Fase 2
ClinicalTrials.gov
Phase 2 Clinical Trial of Bi-weekly Dosing of Irofulven Plus Capecitabine in Patients With Anaplastic or Locally Advanced/Metastatic Differentiated Thyroid Cancer
INTERVENTIONAL
Inicio: 31 de mar de 2005
ID: NCT00124527
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma
INTERVENTIONAL
Inicio: 12 de mar de 2025
ID: NCT06615479
Desconocido
ClinicalTrials.gov
Lupus Flares and Histological Renal Activity at the End of the Treatment
OBSERVATIONAL
Inicio: 1 de ene de 2014
ID: NCT02313974
Completado
Fase 3
ClinicalTrials.gov
A Long-Term Extension Study to Demonstrate Safety of Tildrakizumab in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.
INTERVENTIONAL
Inicio: 11 de jul de 2018
ID: NCT03552276
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults With IgA Nephropathy (The BEYOND Study)
INTERVENTIONAL
Inicio: 6 de jul de 2023
ID: NCT05852938
Completado
Fase 3
ClinicalTrials.gov
A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults With COVID-19.
INTERVENTIONAL
Inicio: 19 de oct de 2020
ID: NCT04575597
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Controlled, Open Label, Two Arms, Exploratory Study to Evaluate the Effect of Everolimus on Histologically Assessed Fibrosis Progression (Ishak-Knodell) in Liver Transplant Recipients With Recurrent Hepatitis C Viral Infection as Compared to Standard Treatment.
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00582738
Completado
ClinicalTrials.gov
Real-world Data of Moderate to Severe Inflammatory Bowel Disease in Argentina: A Non-interventional, Multicenter Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life
OBSERVATIONAL
Inicio: 12 de dic de 2018
ID: NCT03488030
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial of Pembrolizumab (MK-3475) in Combination With Cisplatin and 5-Fluorouracil Versus Placebo in Combination With Cisplatin and 5-Fluorouracil as First-Line Treatment in Subjects With Advanced/Metastatic Esophageal Carcinoma (KEYNOTE-590)
INTERVENTIONAL
Inicio: 25 de jul de 2017
ID: NCT03189719
Completado
Fase 3
ClinicalTrials.gov
LUX-Breast 1; An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment
INTERVENTIONAL
Inicio: 22 de jun de 2010
ID: NCT01125566
Completado
ClinicalTrials.gov
Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HORMONE RECEPTOR POSITIVE/ HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE (HR+/HER2-) Advanced/Metastatic Breast Cancer In Real World Settings
OBSERVATIONAL
Inicio: 15 de may de 2019
ID: NCT05155566
Retirado
Fase 4
ClinicalTrials.gov
Topical Morphine for Analgesia in Pediatric Procedures. Clinical Trial Randomized, Double-blind, Placebo.
INTERVENTIONAL
Inicio: 1 de dic de 2014
ID: NCT02300194
Activo, no recluta
ClinicalTrials.gov
OptimAIR: Towards Right Care in Asthma Through Point-of-care Phenotyping, Guideline-based Assessment and Management Optimalisation Using the AsthmaOptimiser in Primary Care
INTERVENTIONAL
Inicio: 1 de may de 2025
ID: NCT07390669
Completado
Fase 2
ClinicalTrials.gov
An Eight- Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group Proof of Concept Study to Assess the Efficacy, Safety and Tolerability as Well as the Pharmacokinetic Profile of Oral Solabegron (GW427353) 125mg and 50mg Administered Twice Daily vs Placebo in Women With Overactive Bladder
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00343486
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Phase III Study Comparing Biosimilar Rituximab (RTXM83) Plus CHOP Chemotherapy Versus a Reference Rituximab Plus CHOP (R-CHOP) in Patients With Diffuse Large B-cell Lymphoma (DLBCL) Given as First Line
INTERVENTIONAL
Inicio: 1 de may de 2013
ID: NCT02268045
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis
INTERVENTIONAL
Inicio: 3 de dic de 2025
ID: NCT06979453
Terminado
Fase 3
ClinicalTrials.gov
A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00496002
Completado
ClinicalTrials.gov
Laparoscopic Treatment for Appendicitis During Pregnancy: Retrospective Cohort Study
OBSERVATIONAL
Inicio: 1 de sept de 2005
ID: NCT04753502
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, Without Type 2 Diabetes
INTERVENTIONAL
Inicio: 6 de feb de 2026
ID: NCT07321886
Anterior
1
...
429
430
431
...
434
Siguiente
Filtros